NCT00433888 - Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) | Biotech Hunter

Enrollment

179

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

October 31, 2008

Conditions

Hemodialysis Patients

Interventions

DRUG

R744

100μg/4 weeks for 8 weeks,then 25\~400μg/4 weeks for 40 weeks

DRUG

R744

150μg/4 weeks for 8 weeks,then 25\~400μg/4 weeks for 40 weeks

Trial Locations (6)

Chugoku/Shikoku region, Chugoku/Shikoku

Chubu region, Chūbu

Hokkaido/Tohoku region, Hokkaido/Tohoku

Kanto/Koshinetsu region, Kanto/Koshinetsu

Kinki/Hokuriku region, Kinki/Hokuriku

Kyusyu region, Kyusyu